Newstral
Article
Sydney Morning Herald on 2018-04-25 06:28
First drug approved for most common inherited kidney disease
Related news
- First drug approved for most common inherited kidney diseaseSydney Morning Herald
- First Drug Approved for Most Common Inherited Kidney Diseasememphisdailynews.com
- MKaloBios approved for Chagas disease drug dealmarketwatch.com
- Plano’s Reata Pharmaceuticals halts chronic kidney disease drug developmentDallas News
- Study finds diabetes drug may prevent, slow kidney diseaseSeattle Times
- PFDA approves Amgen’s Parsabiv drug to treat chronic kidney diseasepacbiztimes.com
- FDA approves Alnylam's first-ever drug for rare kidney diseasebizjournals.com
- Spark's Luxturna first gene therapy for inherited eye diseasecleveland.com
- Drugs fail to slow decline in inherited Alzheimer's diseasereviewtimes.com
- Drugs fail to slow decline in inherited Alzheimer’s diseaseThe Findlay Courier
- Alzheimer's drug that could slow disease approved by FDAKVUE News
- First Alzheimer’s Drug to Slow Disease Is Approved by FDAwsj.com
- BArdelyx Skyrockets. Its Kidney Disease Drug Is a Step Closer to FDA Approval.4 min readbarrons.com
- SFDA approves drug for cats with chronic kidney disease, giving pet owners hopesilive.com
- Drugs fail to slow decline in inherited Alzheimer’s disease - Mon, 10 Feb 2020 PSTThe Spokesman-Review
- First drug for severe form of fatty liver disease approved: All about itThe Times of India
- Mount Dora boy among first to receive approved gene therapy drug for eye diseaseOrlando Sentinel